Condition: Primary Antibody Deficiency Disorders · Sponsor: Yale University
The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.
This description comes directly from the study's public registry record.
Ryan Steele, DO, MSc · 203-785-7092 · r.steele@yale.edu
Always discuss trial participation with your own doctor first.
| Bridgeport Hospital | Milford, Connecticut, United States | Recruiting |
| Yale New Haven Health | North Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07698197